ASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spain

Vicente Baz, D.Paredes Lario, A.Moran Bueno, M. T.Massuti Sureda, B.Reguard, N.Alvarez, R.Insa Molla, A.Juan, O.Marquez, G.Provencio Pulla, M.2025-01-072025-01-072018-04-011556-0864https://hdl.handle.net/10668/27572enASTRIS, a real-world study with osimertinib in patients with non-small cell lung cancer (NSCLC) EGFR T790M mutated: Characteristics and diagnostic methods used for patients included in Spainconference outputopen access10.1016/S1556-0864(18)30430-11556-1380http://www.jto.org/article/S1556086418304301/pdf436557600151